Royal Bank Of Canada Rvl Pharmaceuticals PLC Transaction History

Royal Bank Of Canada

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.08 - $0.55 $27 - $190	-347 Reduced 37.03%	590 $0
Q2 2023 Aug 14, 2023	BUY	$0.56 - $1.17 $524 - $1,096	937 New	937 $0
Q3 2022 Nov 14, 2022	BUY	$1.28 - $2.91 $268 - $611	210 Added 250.0%	294 $1,000
Q2 2022 Aug 15, 2022	SELL	$1.21 - $1.81 $2,472 - $3,697	-2,043 Reduced 96.05%	84 $0
Q1 2022 May 16, 2022	SELL	$1.03 - $2.01 $266 - $520	-259 Reduced 10.85%	2,127 $3,000
Q4 2021 Feb 14, 2022	BUY	$0.98 - $3.06 $445 - $1,392	455 Added 23.56%	2,386 $2,000
Q3 2021 Nov 15, 2021	BUY	$2.79 - $4.19 $474 - $712	170 Added 9.65%	1,931 $5,000
Q2 2021 Aug 16, 2021	BUY	$2.8 - $3.78 $4,930 - $6,656	1,761 New	1,761 $5,000

92.5K

Ticker RVLP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,150,000
Description
RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.